In this article, we discuss the 5 most profitable biotech companies in the world. In order to read our detailed analysis of the biotech industry, its history, performance, and outlook for future growth, go directly to 10 Most Profitable Biotech Companies in the World.
5. Roche Holding AG (OTC:RHHBY)
Number of Hedge Fund Holders: 3
Net Income (TTM): $15.09 billion
Roche Holding AG (OTC: RHHBY) is one of the largest and most profitable biotech firms in the world. The Switzerland-based company provides treatments for cancer, hepatitis, HIV/AIDS, and anemia, as well as for diseases in the areas of ophthalmology, dermatology, and immunology among others. The firm also provides the research market with diagnostic instruments and test kits and is also one of the leading manufacturers of COVID-19 tests. Founded in 1896, Roche Holding AG (OTC: RHHBY) has a long history of delivering groundbreaking biotech products.
Roche Holding AG (OTC: RHHBY) was the first company to mass-produce synthetic vitamin C, under the brand name Redoxon in 1934. Roche is also the leading provider of cancer treatments around the world. It developed the tranquilizer drug class called benzodiazepines, with antidepressants Valium and Rohypnol the most famous names under this drug family. Roche Holding AG (OTC: RHHBY) is also the sole authorized manufacturer of a bird flu drug called Oseltamivir, which was discovered by Gilead Sciences.
Revenue for 2021 for the biotech giant stood at $72.04 billion, signaling an increase of 11.94% year on year. Fisher Asset Management of billionaire Ken Fisher was the top shareholder of Roche Holding AG (OTC: RHHBY) in the fourth quarter, with 4.65 million shares valued at $242.3 million.
Harding Loevner, an investment firm, talked about Roche Holding AG (OTC: RHHBY) in its Q4 2021 investor letter. The fund said:
“Health Care boosted relative performance as our holdings benefitted from the pandemic both coming and going. Roche and Lonza saw heightened interest in treatment, testing, and vaccination activities to battle the waves of newer COVID-19 variants.